167 related articles for article (PubMed ID: 28704821)
1. Application of the DruGeVar Database in Cancer Genomics and Pharmacogenomics.
Sarris K; Komianou A; Patrinos GP; Katsila T
Public Health Genomics; 2017; 20(2):142-147. PubMed ID: 28704821
[TBL] [Abstract][Full Text] [Related]
2. DruGeVar: an online resource triangulating drugs with genes and genomic biomarkers for clinical pharmacogenomics.
Dalabira E; Viennas E; Daki E; Komianou A; Bartsakoulia M; Poulas K; Katsila T; Tzimas G; Patrinos GP
Public Health Genomics; 2014; 17(5-6):265-71. PubMed ID: 25228099
[TBL] [Abstract][Full Text] [Related]
3. Expanded national database collection and data coverage in the FINDbase worldwide database for clinically relevant genomic variation allele frequencies.
Viennas E; Komianou A; Mizzi C; Stojiljkovic M; Mitropoulou C; Muilu J; Vihinen M; Grypioti P; Papadaki S; Pavlidis C; Zukic B; Katsila T; van der Spek PJ; Pavlovic S; Tzimas G; Patrinos GP
Nucleic Acids Res; 2017 Jan; 45(D1):D846-D853. PubMed ID: 27924022
[TBL] [Abstract][Full Text] [Related]
4. Exploratory visual analysis of pharmacogenomic results.
Reif DM; Dudek SM; Shaffer CM; Wang J; Moore JH
Pac Symp Biocomput; 2005; ():296-307. PubMed ID: 15759635
[TBL] [Abstract][Full Text] [Related]
5. Methods to analyze big data in pharmacogenomics research.
Li R; Kim D; Ritchie MD
Pharmacogenomics; 2017 Jun; 18(8):807-820. PubMed ID: 28612644
[TBL] [Abstract][Full Text] [Related]
6. Population-specific documentation of pharmacogenomic markers and their allelic frequencies in FINDbase.
Georgitsi M; Viennas E; Gkantouna V; Christodoulopoulou E; Zagoriti Z; Tafrali C; Ntellos F; Giannakopoulou O; Boulakou A; Vlahopoulou P; Kyriacou E; Tsaknakis J; Tsakalidis A; Poulas K; Tzimas G; Patrinos GP
Pharmacogenomics; 2011 Jan; 12(1):49-58. PubMed ID: 21174622
[TBL] [Abstract][Full Text] [Related]
7. Deciphering next-generation pharmacogenomics: an information technology perspective.
Potamias G; Lakiotaki K; Katsila T; Lee MT; Topouzis S; Cooper DN; Patrinos GP
Open Biol; 2014 Jul; 4(7):. PubMed ID: 25030607
[TBL] [Abstract][Full Text] [Related]
8. Integrating heterogeneous drug sensitivity data from cancer pharmacogenomic studies.
Pozdeyev N; Yoo M; Mackie R; Schweppe RE; Tan AC; Haugen BR
Oncotarget; 2016 Aug; 7(32):51619-51625. PubMed ID: 27322211
[TBL] [Abstract][Full Text] [Related]
9. Databases and web tools for cancer genomics study.
Yang Y; Dong X; Xie B; Ding N; Chen J; Li Y; Zhang Q; Qu H; Fang X
Genomics Proteomics Bioinformatics; 2015 Feb; 13(1):46-50. PubMed ID: 25707591
[TBL] [Abstract][Full Text] [Related]
10. GDSCTools for mining pharmacogenomic interactions in cancer.
Cokelaer T; Chen E; Iorio F; Menden MP; Lightfoot H; Saez-Rodriguez J; Garnett MJ
Bioinformatics; 2018 Apr; 34(7):1226-1228. PubMed ID: 29186349
[TBL] [Abstract][Full Text] [Related]
11. Survival analysis tools in genomics research.
Chen X; Sun X; Hoshida Y
Hum Genomics; 2014 Nov; 8(1):21. PubMed ID: 25421963
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics and pharmacogenomics as tools in cancer therapy.
Rodríguez-Vicente AE; Lumbreras E; Hernández JM; Martín M; Calles A; Otín CL; Algarra SM; Páez D; Taron M
Drug Metab Pers Ther; 2016 Mar; 31(1):25-34. PubMed ID: 26863347
[TBL] [Abstract][Full Text] [Related]
13. HLBS-PopOmics: an online knowledge base to accelerate dissemination and implementation of research advances in population genomics to reduce the burden of heart, lung, blood, and sleep disorders.
Mensah GA; Yu W; Barfield WL; Clyne M; Engelgau MM; Khoury MJ
Genet Med; 2019 Mar; 21(3):519-524. PubMed ID: 30197419
[TBL] [Abstract][Full Text] [Related]
14. Population-ethnic group specific genome variation allele frequency data: a querying and visualization journey.
Viennas E; Gkantouna V; Ioannou M; Georgitsi M; Rigou M; Poulas K; Patrinos GP; Tzimas G
Genomics; 2012 Aug; 100(2):93-101. PubMed ID: 22659238
[TBL] [Abstract][Full Text] [Related]
15. Expression genomics and drug development: towards predictive pharmacology.
Liu ET
Brief Funct Genomic Proteomic; 2005 Feb; 3(4):303-21. PubMed ID: 15814022
[TBL] [Abstract][Full Text] [Related]
16. MILANO--custom annotation of microarray results using automatic literature searches.
Rubinstein R; Simon I
BMC Bioinformatics; 2005 Jan; 6():12. PubMed ID: 15661078
[TBL] [Abstract][Full Text] [Related]
17. PharmacoDB 2.0: improving scalability and transparency of in vitro pharmacogenomics analysis.
Feizi N; Nair SK; Smirnov P; Beri G; Eeles C; Esfahani PN; Nakano M; Tkachuk D; Mammoliti A; Gorobets E; Mer AS; Lin E; Yu Y; Martin S; Hafner M; Haibe-Kains B
Nucleic Acids Res; 2022 Jan; 50(D1):D1348-D1357. PubMed ID: 34850112
[TBL] [Abstract][Full Text] [Related]
18. SIGMA: a system for integrative genomic microarray analysis of cancer genomes.
Chari R; Lockwood WW; Coe BP; Chu A; Macey D; Thomson A; Davies JJ; MacAulay C; Lam WL
BMC Genomics; 2006 Dec; 7():324. PubMed ID: 17192189
[TBL] [Abstract][Full Text] [Related]
19. Beyond the clinic: 'direct-to-consumer' genomic profiling services and pharmacogenomics.
Prainsack B; Vayena E
Pharmacogenomics; 2013 Mar; 14(4):403-12. PubMed ID: 23438887
[TBL] [Abstract][Full Text] [Related]
20. PGMD: a comprehensive manually curated pharmacogenomic database.
Kaplun A; Hogan JD; Schacherer F; Peter AP; Krishna S; Braun BR; Nambudiry R; Nitu MG; Mallelwar R; Albayrak A
Pharmacogenomics J; 2016 Apr; 16(2):124-8. PubMed ID: 25939485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
